Overview

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Status:
Active, not recruiting

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether lenalidomide can stop the growth of leukemia stem cells and can be used to prevent the return of leukemia cells after a transplant.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, Davis

Collaborator:

Celgene

Treatments:

Lenalidomide
Thalidomide